Tumanggong, Abdul Rahman .

HRN: 19-63-81  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/09/2022
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
08/09/2022
08/13/2022
ORAL
4ml
Q8
Intestinal Amebiasis
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: